Kuwait vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Treatment for hypertension, male
Treatment for hypertension, male over time
- Kuwait
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
How they compare
Kuwait currently reports 51.2% against 31.1% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 20.1%.
That makes Kuwait's figure about 1.6 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.
Across all 30 years both countries report, Kuwait has been ahead every year.
Kuwait ranks 27th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 28th of 192 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kuwait | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 24.4% | 17.1% | 7.3% | Kuwait |
| 2000s | 35.4% | 23.8% | 11.5% | Kuwait |
| 2010s | 47.6% | 29.8% | 17.8% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, male, Kuwait or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- Kuwait, at 51.2% against 31.1% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2019.
- What is the difference in treatment for hypertension, male between Kuwait and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 20.1%, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 30 years are reported by both, from 1990 to 2019.
- How do Kuwait and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for treatment for hypertension, male?
- Kuwait ranks 27th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 28th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.